RESEARCH TRIANGLE PARK, N.C., March 10, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Epilepsy Therapy Project’s Pipeline Update Conference; “Portal into CNS Opportunities,” to be held March 13, 2008, at The Hotel Monaco in San Francisco. Greg Rigdon, Ph.D., Vice President, New Product Development, is scheduled to present a brief overview of Icagen’s clinical product candidate, ICA-105665, as a potential treatment for epilepsy.
